RecruitingNot ApplicableNCT06724718

Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch


Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

302 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a consumer smartwatch can reliably detect atrial fibrillation (an irregular heartbeat) in patients who develop it after major lung surgery (such as removal of a lobe or an entire lung). **You may be eligible if...** - Age 18 or older - Underwent major lung surgery (pneumonectomy or lobectomy) requiring one-lung ventilation within the past 48 hours - Admitted to a conventional (non-ICU) surgical unit after surgery - Able to use the single-lead ECG feature on a smartwatch **You may NOT be eligible if...** - Already in the ICU after surgery - Unable to use or tolerate wearing a smartwatch - Had a different type of thoracic surgery not covered by the protocol Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERsmartwatch

Patients in the smartwatch group will undergo rhythm monitoring with a smartwatch

OTHERECG

Detected POAF episodes will be confirmed via a 12-lead ECG


Locations(1)

Centre hospitalier Amiens

Amiens, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06724718


Related Trials